MoneyWorks4Me

Glenmark Pharmaceuticals allots 61,300 shares under ESOS

19 Aug 2013 Evaluate

Glenmark Pharmaceuticals has informed that the Operations Committee of the Board of Directors of the Company, at its Meeting held on August 17, 2013 allotted 61,300 shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..